Posted on Leave a comment

Recreational cannabis legal in Germany despite criticism*

Flag of Germany

« These non-profit associations will be able to sell to their members a maximum of 25 grams per day and no more than 50 grams per month. »*

Georg Wurth, representative of the German hemp federation

After Malta in 2021 and Luxembourg last year, Germany on Monday became the largest EU country to legalize the recreational use of cannabis, with a reform that raises as many expectations as fears, reports RTS.*

At midnight, the time of the first “legal” joints, several hundred people celebrated the change in law in plumes of smoke in front of the emblematic Brandenburg Gate, in the heart of Berlin. Possession of 25 grams of dried cannabis is now authorized in public places, as well as cultivation at home, up to 50 g and three plants per adult.*

A different approach from that of the Netherlands, where the consumption of hashish is not legal but tolerated, in particular through “coffeeshops”. Paradoxically, you will have to wait another three months in Germany to legally buy drugs via a “Cannabis Social Club”.*

Maximum of 25 grams per day*

Hence the warning in the meantime from Georg Wurth, representative of the German hemp federation: despite legalization “the consumer must not tell the policeman where he bought his cannabis” in the event of a control in the Street.*

“Because from April 1 we can in principle only obtain drugs illegally,” he said in an interview with AFP. The situation will really change on July 1 with the clubs. These non-profit associations will be able to sell to their members a maximum of 25 grams per day and no more than 50 grams per month.*

Shared cannabis gardens*

These clubs, a sort of shared cannabis garden, will be able to cultivate the drug on land outside, in a greenhouse, in an uninhabited building. Controlled at least once a year by the authorities, each association will be able to accommodate, in return for a contribution, a maximum of 500 people who have been residing in Germany for at least 6 months.*

According to the government, the new legislation, ardently desired by environmentalists and liberals in the coalition of Social Democratic Chancellor Olaf Scholz, should make it possible to fight more effectively against trafficking. Believing that the policy of prohibition has failed, Health Minister Karl Lauterbach regularly argues that countries like Canada, which have implemented legalization, have been able to reduce the black market.*

But many medical associations fear an increase in consumption, particularly among young people. Up to the age of 25, cannabis consumption carries increased risks for the brain which is still forming, according to experts, who point out in particular the danger of developing psychotic disorders such as schizophrenia.*

Prohibited under 18*

For Katja Seidel, specialist in addiction prevention at the Tannenhof Center in Berlin, the new law is “a catastrophe”. The German Minister of Health has promised increased means to educate young people about the dangers of cannabis, without announcing precise amounts.*

The authorities argue that cannabis remains prohibited for those under 18. Its consumption is also within a radius of 100 meters around schools, nurseries, playgrounds. The police are also up in arms against what they consider a “bureaucratic monster with a lot of piecemeal regulations”, according to the president of the branch union (DPolG), Rainer Wendt.*

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

The canton of Zurich launches the largest Swiss study on the controlled sale of cannabis*

Flag of Switzerland

« The scientific focus is on the social and economic consequences of cannabis consumption. It will thus be possible to study whether legal cannabis has a positive effect on health and educational attainment. It will also be a question of identifying whether ease of access to cannabis increases consumption. »*

Andreas Beerli, ETH Zurich’s Center for Economic Research

After the cities of Basel, Zurich and Lausanne, as well as the canton of Geneva, the canton of Zurich will launch the controlled sale of cannabis on May 2. With 7,500 participants expected, it is the largest pilot project of this type in Switzerland, reports RTS.*

The University of Zurich and the Zurich Polytechnic are responsible for the scientific evaluation of the pilot project in the canton of Zurich, which has been authorized by the Federal Office of Public Health (FOPH). The study is expected to last five years and will cost around 1.4 million francs, Paul-Lukas Good, president of Swiss Cannabis Research, said on Monday.*

According to Andreas Beerli from the ETH Zurich’s Center for Economic Research, the scientific focus is on the social and economic consequences of cannabis consumption. It will thus be possible to study whether legal cannabis has a positive effect on health and educational attainment. It will also be a question of identifying whether ease of access to cannabis increases consumption.*

Pharmacies and points of sale*

Participants will be able to obtain cannabis in pharmacies and points of sale in 34 municipalities in the canton. Three kinds of cannabis will be available with THC contents of 15%, 9% and 6%, said Paul Lukas Good.*

Participants will be divided into three groups of 2,500 people each. Two groups will have access to regulated cannabis and the third will continue to obtain products on the black market. Andreas Beerli hopes that the comparison between these groups will make it possible to draw conclusions on the effect of regulated sales and to identify differences between town and country or in the age of consumers.*

The cities of Basel, Zurich and Lausanne and the canton of Geneva have already launched their trials. They were authorized by the OFSP. Similar projects are also planned in Bern and St. Gallen.

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

Recreational cannabis legal in Germany from April 1*

Flag of Germany

« The regulations provide for authorizing the purchase of cannabis in limited quantities of 25 grams per day maximum through non-profit associations. It will also be possible to grow up to three plants for your own use. »*

health Minister

Buying cannabis or growing it at home for pleasure will be legal from April 1 in Germany. The German Parliament definitively voted on Friday, after intense debates, one of the most liberal laws in Europe, reports RTS.*

This flagship law for the government of Social Democratic Chancellor (SPD) Olaf Scholz was adopted by 407 votes to 226, after having been the subject of numerous criticisms and a heated debate in the Bundestag, the lower house of parliament.*

The regulations provide for authorizing the purchase of cannabis in limited quantities of a maximum of 25 grams per day through non-profit associations. It will also be possible to grow up to three plants for your own use. However, the possession and consumption of this drug will remain strictly prohibited for young people under the age of 18.*

With this new law, Germany follows in the footsteps of Malta and Luxembourg, which legalized recreational cannabis in 2021 and 2023 respectively.*

Subject to debate*

The project was the subject of dissension within the tripartite government: resistance appeared among the social democrats, while the Greens and the liberals of the FDP, their partners in the government, were rather favorable.*

This reform has also given rise to numerous criticisms, particularly from medical associations and the judiciary. The current law provides for a fine and, in the most serious cases, up to prison sentences, for possession of cannabis.*

Population not entirely supportive*

The Germans seem rather divided on the question: according to a poll published Friday, 47% of those questioned are in favor of legalization and 42% are unfavorable.*

For the government, the reform must make it possible to fight more effectively against the black market, a point contested by the conservative opposition, the police unions and certain SPD deputies.*

Consumption remains prohibited near minors, schools, nurseries and sports facilities. The cultivation and distribution of cannabis will only be possible from July 1 via associations called “Cannabis Clubs”.*

These clubs will be able to sell a maximum of 25 grams per day and no more than 50 grams per month to their members, 500 people at most. Only adults can become members. Between 18 and 21 years old, they will only be able to obtain 30 grams per month of cannabis with a level of active ingredient THC limited to 10%.*

These clubs will also be responsible for distributing cannabis seeds and cuttings to their members for home cultivation, up to a maximum of seven seeds or five cuttings.*

Awareness campaign*

Recognizing that overconsumption of cannabis could be “dangerous” for young people, whose brains develop up to the age of 25, the Minister of Health announced that an awareness campaign would be put in place.*

Secondly, the sale should be legalized in specialized stores under a new law which will allow this process to first be tested in certain regions, not yet designated, for five years.*

* original article

** image

*** ndlr. : –.

Posted on Leave a comment

Endocannabinoid Signaling Regulates Sleep Stability*

PLOS ONE logo
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Medical Cannabis and Cannabinoids for Impaired Sleep: A Systematic Review and Meta-Analysis of Randomized Clinical Trials*

logo Sleep
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review

logo CPJRPC
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Treating Insomnia Symptoms with Medicinal Cannabis: A Randomized, Cross-Over Trial of the Efficacy of a Cannabinoid Medicine Compared with Placebo

logo Sleep®
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.

Posted on Leave a comment

Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial

Frontiers in medicine
Désolé, vous n’êtes pas autorisé-e à voir ce contenu. Pour voir cette page, il  faut vous connecter à votre compte avec privilège.

Sorry, you are not authorized to view this content. To view this page, you must log into your account with privilege.

Login

NOUVELLE INSCRIPTION / NEW REGISTRATION

Si vous n’avez pas encore de compte avec privilège, il est nécessaire de nous envoyer une demande spécifique par courriel (info@86avenue.ch) après création d’un compte standard. Des justificatifs pourrons vous être demandés, confirmant votre statut de personne impliquée dans le domaine médical ou titulaire d’une autorisation. Un privilège sera ensuite attribué à votre profil.

Vous pouvez également remplir le FORMULAIRE D‘INSCRIPTION pour l’obtention du privilège. Ce service est TOTALEMENT GRATUIT.

En vous enregistrant sous votre profil avec privilège, vous pourrez accéder aux articles médicaux et assimilés, ainsi qu’à leurs résumés. Nous regrettons cette situation qui pourrait exposer notre entreprise à des sanctions légales.

 

If you do not yet have a privileged account, it is necessary to send us a specific request by email (info@86avenue.ch) after creating a standard account. Evidence may be requested, confirming your status as a person involved in the medical field or holder of an authorization. A privilege will then be assigned to your profile.

You can also complete the REGISTRATION FORM for obtaining the privilege. This service is TOTALLY FREE.

By registering under your profile with privilege, you will be able to access medical and similar articles, as well as their summaries. We regret this situation which could expose our company to legal sanctions.